Global Alzheimer’s Disease Diagnostic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 791
  • calendar_today Published On: Feb, 2020
  • file_copy Pages: 101
  • list Pharmaceutics
Buy @ $3480
Description

Scope of the Report:
The global Alzheimer’s Disease Diagnostic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Alzheimer’s Disease Diagnostic.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Alzheimer’s Disease Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Alzheimer’s Disease Diagnostic market by product type and applications/end industries.

Market Segment by Companies, this report covers
Eli Lilly and Company
Accera
F. Hoffmann-La Roche
Novartis
Alector
Merck
Neuro-Bio
TauRx
Pfizer
Treventis Corporation
Cognition Therapeutics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Nervous System Examination
Genetic Testing
Minor Mental State Examination (Mmse)
Brain Imaging

Market Segment by Applications, can be divided into
Early-Onset Alzheimer's Disease
Familial Alzheimer's Disease
Late-Onset Alzheimer's Disease
Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Alzheimer’s Disease Diagnostic Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Diagnostic
1.2 Classification of Alzheimer’s Disease Diagnostic by Types
1.2.1 Global Alzheimer’s Disease Diagnostic Revenue Comparison by Types (2019-2024)
1.2.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Types in 2018
1.2.3 Nervous System Examination
1.2.4 Genetic Testing
1.2.5 Minor Mental State Examination (Mmse)
1.2.6 Brain Imaging
1.3 Global Alzheimer’s Disease Diagnostic Market by Application
1.3.1 Global Alzheimer’s Disease Diagnostic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Early-Onset Alzheimer's Disease
1.3.3 Familial Alzheimer's Disease
1.3.4 Late-Onset Alzheimer's Disease
1.4 Global Alzheimer’s Disease Diagnostic Market by Regions
1.4.1 Global Alzheimer’s Disease Diagnostic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Alzheimer’s Disease Diagnostic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Alzheimer’s Disease Diagnostic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alzheimer’s Disease Diagnostic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Alzheimer’s Disease Diagnostic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alzheimer’s Disease Diagnostic Status and Prospect (2014-2024)
1.5 Global Market Size of Alzheimer’s Disease Diagnostic (2014-2024)
2 Company Profiles
2.1 Eli Lilly and Company
2.1.1 Business Overview
2.1.2 Alzheimer’s Disease Diagnostic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.2 Accera
2.2.1 Business Overview
2.2.2 Alzheimer’s Disease Diagnostic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Accera Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Alzheimer’s Disease Diagnostic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Alzheimer’s Disease Diagnostic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Alector
2.5.1 Business Overview
2.5.2 Alzheimer’s Disease Diagnostic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Alector Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.6 Merck
2.6.1 Business Overview
2.6.2 Alzheimer’s Disease Diagnostic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.7 Neuro-Bio
2.7.1 Business Overview
2.7.2 Alzheimer’s Disease Diagnostic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Neuro-Bio Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.8 TauRx
2.8.1 Business Overview
2.8.2 Alzheimer’s Disease Diagnostic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 TauRx Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Alzheimer’s Disease Diagnostic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.10 Treventis Corporation
2.10.1 Business Overview
2.10.2 Alzheimer’s Disease Diagnostic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Treventis Corporation Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
2.11 Cognition Therapeutics
2.11.1 Business Overview
2.11.2 Alzheimer’s Disease Diagnostic Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
3 Global Alzheimer’s Disease Diagnostic Market Competition, by Players
3.1 Global Alzheimer’s Disease Diagnostic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Alzheimer’s Disease Diagnostic Players Market Share
3.2.2 Top 10 Alzheimer’s Disease Diagnostic Players Market Share
3.3 Market Competition Trend
4 Global Alzheimer’s Disease Diagnostic Market Size by Regions
4.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Regions
4.2 North America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
4.3 Europe Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
4.5 South America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
5 North America Alzheimer’s Disease Diagnostic Revenue by Countries
5.1 North America Alzheimer’s Disease Diagnostic Revenue by Countries (2014-2019)
5.2 USA Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
5.3 Canada Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
5.4 Mexico Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
6 Europe Alzheimer’s Disease Diagnostic Revenue by Countries
6.1 Europe Alzheimer’s Disease Diagnostic Revenue by Countries (2014-2019)
6.2 Germany Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
6.3 UK Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
6.4 France Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
6.5 Russia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
6.6 Italy Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Countries
7.1 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Countries (2014-2019)
7.2 China Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
7.3 Japan Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
7.4 Korea Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
7.5 India Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
8 South America Alzheimer’s Disease Diagnostic Revenue by Countries
8.1 South America Alzheimer’s Disease Diagnostic Revenue by Countries (2014-2019)
8.2 Brazil Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
8.3 Argentina Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
8.4 Colombia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Alzheimer’s Disease Diagnostic by Countries
9.1 Middle East and Africa Alzheimer’s Disease Diagnostic Revenue by Countries (2014-2019)
9.2 Saudi Arabia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
9.3 UAE Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
9.4 Egypt Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
9.5 Nigeria Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
9.6 South Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
10 Global Alzheimer’s Disease Diagnostic Market Segment by Type
10.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2014-2019)
10.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Type (2019-2024)
10.3 Nervous System Examination Revenue Growth Rate (2014-2024)
10.4 Genetic Testing Revenue Growth Rate (2014-2024)
10.5 Minor Mental State Examination (Mmse) Revenue Growth Rate (2014-2024)
10.6 Brain Imaging Revenue Growth Rate (2014-2024)
11 Global Alzheimer’s Disease Diagnostic Market Segment by Application
11.1 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2014-2019)
11.2 Alzheimer’s Disease Diagnostic Market Forecast by Application (2019-2024)
11.3 Early-Onset Alzheimer's Disease Revenue Growth (2014-2019)
11.4 Familial Alzheimer's Disease Revenue Growth (2014-2019)
11.5 Late-Onset Alzheimer's Disease Revenue Growth (2014-2019)
12 Global Alzheimer’s Disease Diagnostic Market Size Forecast (2019-2024)
12.1 Global Alzheimer’s Disease Diagnostic Market Size Forecast (2019-2024)
12.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Regions (2019-2024)
12.3 North America Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
12.4 Europe Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
12.6 South America Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Alzheimer’s Disease Diagnostic Picture
Table Product Specifications of Alzheimer’s Disease Diagnostic
Table Global Alzheimer’s Disease Diagnostic and Revenue (Million USD) Market Split by Product Type
Figure Global Alzheimer’s Disease Diagnostic Revenue Market Share by Types in 2018
Figure Nervous System Examination Picture
Figure Genetic Testing Picture
Figure Minor Mental State Examination (Mmse) Picture
Figure Brain Imaging Picture
Table Global Alzheimer’s Disease Diagnostic Revenue (Million USD) by Application (2014-2024)
Figure Alzheimer’s Disease Diagnostic Revenue Market Share by Applications in 2018
Figure Early-Onset Alzheimer's Disease Picture
Figure Familial Alzheimer's Disease Picture
Figure Late-Onset Alzheimer's Disease Picture
Table Global Market Alzheimer’s Disease Diagnostic Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate (2014-2024)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Alzheimer’s Disease Diagnostic Type and Applications
Table Eli Lilly and Company Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Accera Basic Information, Manufacturing Base and Competitors
Table Accera Alzheimer’s Disease Diagnostic Type and Applications
Table Accera Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Type and Applications
Table F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Alzheimer’s Disease Diagnostic Type and Applications
Table Novartis Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Alector Basic Information, Manufacturing Base and Competitors
Table Alector Alzheimer’s Disease Diagnostic Type and Applications
Table Alector Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Alzheimer’s Disease Diagnostic Type and Applications
Table Merck Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Neuro-Bio Basic Information, Manufacturing Base and Competitors
Table Neuro-Bio Alzheimer’s Disease Diagnostic Type and Applications
Table Neuro-Bio Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table TauRx Basic Information, Manufacturing Base and Competitors
Table TauRx Alzheimer’s Disease Diagnostic Type and Applications
Table TauRx Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Alzheimer’s Disease Diagnostic Type and Applications
Table Pfizer Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Treventis Corporation Basic Information, Manufacturing Base and Competitors
Table Treventis Corporation Alzheimer’s Disease Diagnostic Type and Applications
Table Treventis Corporation Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Cognition Therapeutics Basic Information, Manufacturing Base and Competitors
Table Cognition Therapeutics Alzheimer’s Disease Diagnostic Type and Applications
Table Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2017-2018)
Table Global Alzheimer’s Disease Diagnostic Revenue (Million USD) by Players (2014-2019)
Table Global Alzheimer’s Disease Diagnostic Revenue Share by Players (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue Share by Players in 2017
Figure Global Alzheimer’s Disease Diagnostic Revenue Share by Players in 2018
Figure Global Top 5 Players Alzheimer’s Disease Diagnostic Revenue Market Share in 2018
Figure Global Top 10 Players Alzheimer’s Disease Diagnostic Revenue Market Share in 2018
Figure Global Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Alzheimer’s Disease Diagnostic Revenue (Million USD) by Regions (2014-2019)
Table Global Alzheimer’s Disease Diagnostic Revenue Market Share by Regions (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue Market Share by Regions (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue Market Share by Regions in 2018
Figure North America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Europe Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure South America Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Table North America Alzheimer’s Disease Diagnostic Revenue by Countries (2014-2019)
Table North America Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure North America Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure North America Alzheimer’s Disease Diagnostic Revenue Market Share by Countries in 2018
Figure USA Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Canada Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Mexico Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Table Europe Alzheimer’s Disease Diagnostic Revenue (Million USD) by Countries (2014-2019)
Figure Europe Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Europe Alzheimer’s Disease Diagnostic Revenue Market Share by Countries in 2018
Figure Germany Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure UK Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure France Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Russia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Italy Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Alzheimer’s Disease Diagnostic Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Alzheimer’s Disease Diagnostic Revenue Market Share by Countries in 2018
Figure China Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Japan Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Korea Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure India Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Table South America Alzheimer’s Disease Diagnostic Revenue by Countries (2014-2019)
Table South America Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure South America Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure South America Alzheimer’s Disease Diagnostic Revenue Market Share by Countries in 2018
Figure Brazil Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Argentina Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Colombia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Alzheimer’s Disease Diagnostic Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alzheimer’s Disease Diagnostic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Alzheimer’s Disease Diagnostic Revenue Market Share by Countries in 2018
Figure Saudi Arabia Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure UAE Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Egypt Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure Nigeria Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Figure South Africa Alzheimer’s Disease Diagnostic Revenue and Growth Rate (2014-2019)
Table Global Alzheimer’s Disease Diagnostic Revenue (Million USD) by Type (2014-2019)
Table Global Alzheimer’s Disease Diagnostic Revenue Share by Type (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue Share by Type (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue Share by Type in 2018
Table Global Alzheimer’s Disease Diagnostic Revenue Forecast by Type (2019-2024)
Figure Global Alzheimer’s Disease Diagnostic Market Share Forecast by Type (2019-2024)
Figure Global Nervous System Examination Revenue Growth Rate (2014-2019)
Figure Global Genetic Testing Revenue Growth Rate (2014-2019)
Figure Global Minor Mental State Examination (Mmse) Revenue Growth Rate (2014-2019)
Figure Global Brain Imaging Revenue Growth Rate (2014-2019)
Table Global Alzheimer’s Disease Diagnostic Revenue by Application (2014-2019)
Table Global Alzheimer’s Disease Diagnostic Revenue Share by Application (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue Share by Application (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue Share by Application in 2018
Table Global Alzheimer’s Disease Diagnostic Revenue Forecast by Application (2019-2024)
Figure Global Alzheimer’s Disease Diagnostic Market Share Forecast by Application (2019-2024)
Figure Global Early-Onset Alzheimer's Disease Revenue Growth Rate (2014-2019)
Figure Global Familial Alzheimer's Disease Revenue Growth Rate (2014-2019)
Figure Global Late-Onset Alzheimer's Disease Revenue Growth Rate (2014-2019)
Figure Global Alzheimer’s Disease Diagnostic Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Alzheimer’s Disease Diagnostic Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Alzheimer’s Disease Diagnostic Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
Figure Europe Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
Figure South America Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Alzheimer’s Disease Diagnostic Revenue Market Forecast (2019-2024)